Clinical trial Recruiting at 1 site Observational

Observational study of genetic variants in neurodevelopmental disorders

Official title: Neurogenetic Disorders: A Longitudinal Study on Natural History and Intervention Strategies

Run by Columbia University · NCT03492060 · Data updated 2026-11-12

This study looks at how certain genetic changes affect people with neurodevelopmental disorders like autism and intellectual disabilities to better understand their treatment and related health issues.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorColumbia University
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJune 13, 2018
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedOctober 27, 2025
Trial IDNCT03492060 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with confirmed genetic variants linked to neurodevelopmental disorders.

Probably not a fit

Patients without a confirmed genetic variant or those unable to provide genetic confirmation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to analyze patterns in individuals with specific genetic variants associated with neurodevelopmental disorders, including autism and intellectual disabilities. It will maintain an ongoing database of medical data collected during routine care and gather prospective data through questionnaires, neuropsychological assessments, and electroencephalography. The focus is on understanding the neurological comorbidities and treatment outcomes related to these genetic variants. The study will include individuals with confirmed variants in any gene presenting with neurodevelopmental abnormalities.

Why it matters

Potential benefit: If successful, this study could enhance understanding of neurodevelopmental disorders and improve patient management strategies.

How similar studies have gone: Other studies have shown success in understanding genetic contributions to neurodevelopmental disorders, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals must have had whole genome/exome sequencing and have a confirmed variant in any gene.

Exclusion Criteria:

* Subjects who cannot provide genetic confirmation of a predicted deleterious variant in any gene.

Where it's running

  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.